PharmaSGP Holding SE Capital Reinvestment Ratio
PharmaSGP Holding SE capital reinvestment ratio. PharmaSGP Holding SE (PSG) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (€4.22 Million) in capital expenditures (€708.00K). Check cash flow reinvestment rate of PharmaSGP Holding SE to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PharmaSGP Holding SE (2014–2024)
Capital reinvestment ratio of PharmaSGP Holding SE from 2014 to 2024. This chart tracks PharmaSGP Holding SE's Capital Reinvestment Ratio across 11 annual periods. Also explore PharmaSGP Holding SE equity growth rate to track the company's year-over-year net asset growth rate.
PharmaSGP Holding SE Capital Reinvestment Ratio by Year (2014–2024)
PharmaSGP Holding SE capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see PSG operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.03x | €26.64 Million | €866.00K | ▲ +569.5% |
| 2022 | 0.00x | €24.71 Million | €120.00K | ▼ -36.8% |
| 2021 | 0.01x | €12.24 Million | €94.00K | ▼ -71.7% |
| 2020 | 0.03x | €15.46 Million | €420.00K | ▲ +14.1% |
| 2019 | 0.02x | €17.63 Million | €420.00K | ▼ -26.7% |
| 2018 | 0.03x | €8.43 Million | €274.00K | ▲ +16.7% |
| 2017 | 0.03x | €14.25 Million | €397.00K | ▼ -99.2% |
| 2016 | 3.35x | €3.55 Million | €11.88 Million | ▲ +731.2% |
| 2015 | 0.40x | €10.59 Million | €4.26 Million | ▲ +8.4% |
| 2014 | 0.37x | €5.41 Million | €2.01 Million | — |